PathAI logo

Machine learning-enabled continuous scoring of histologic features facilitates prediction of clinical disease progression in patients with non-alcoholic steatohepatitis

EASL 2022

Study Background

Here, we report machine learning-facilitated continuous scoring of histologic features by PathAI’s AI-based Measurement of NASH Histology (AIM-NASH) algorithms in a retrospective analysis of a datasets from two completed NASH clinical trials. The prognostic utility of continuous scores was evaluated and compared against ordinal scoring for predicting patient outcomes.
View Poster


Iyer et al.